November 21, 2025 – Dr. Norma Biln, Augurex Co-founder and Chair of the Board, was featured on the Spondycast Podcast, hosted by the Spondylitis Association of America.
🎧 Listen to the full Spondycast episode:
In Episode 121: Closing the Diagnosis Delay in Spondyloarthritis, Dr. Biln discusses how new biomarkers, patient questionnaires, and tools like SPINEstat® (Anti-14-3-3eta Multiplex test) can help shorten the long diagnostic delay in axial spondyloarthritis (axSpA) by improving early detection and referral accuracy in clinical practice.
She highlights how SPINEstat® (Anti-14-3-3eta Multiplex test) helps clinicians distinguish inflammatory axSpA from mechanical back pain, a common challenge that contributes to delayed diagnosis. The test also complements established markers such as CRP and HLA-B27, supporting clearer identification of inflammatory disease. Together, these tools help improve confidence in early clinical assessment.
The conversation underscores the potential of biomarker-based testing and other tools to help address the long-standing diagnostic delays in axSpA, improving confidence in clinical decision-making and supporting timely treatment intervention.